Connor, Clark & Lunn Investment Management Ltd. Haemonetics Corp Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$26 Billion
Q2 2025

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Haemonetics Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 174,287 shares of HAE stock, worth $8.84 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

174,287

Previous 224,372 22.32%

Holding current value

$8.84 Million

Previous $14.3 Million 8.8%

% of portfolio

0.05%

Previous 0.07%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	SELL	$56.04 - $74.77 $2.81 Million - $3.74 Million	-50,085 Reduced 22.32%	174,287 $13 Million
Q1 2025 May 12, 2025	SELL	$59.34 - $80.05 $1.65 Million - $2.22 Million	-27,770 Reduced 11.01%	224,372 $14.3 Million
Q4 2024 Feb 10, 2025	BUY	$71.16 - $93.38 $2.25 Million - $2.96 Million	31,689 Added 14.37%	252,142 $19.7 Million
Q3 2024 Nov 08, 2024	BUY	$72.45 - $91.58 $13 Million - $16.4 Million	179,621 Added 439.9%	220,453 $17.7 Million
Q2 2024 Aug 09, 2024	BUY	$81.24 - $97.37 $3.32 Million - $3.98 Million	40,832 New	40,832 $3.38 Million
Q2 2023 Aug 10, 2023	BUY	$80.84 - $89.45 $1.45 Million - $1.61 Million	17,963 New	17,963 $1.53 Million
Q3 2018 Nov 13, 2018	SELL	$89.96 - $114.58 $341,848 - $435,404	-3,800 Closed	0 $0
Q2 2018 Aug 02, 2018	BUY	$71.53 - $95.75 $271,814 - $363,850	3,800 New	3,800 $341,000
Q4 2017 Feb 09, 2018	SELL	$44.96 - $58.99 $266,388 - $349,515	-5,925 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$40.38 - $44.87 $28,266 - $31,409	700 Added 13.4%	5,925 $266,000
Q2 2017 Aug 14, 2017	BUY	N/A	5,225	5,225 $206,000

Others Institutions Holding HAE

# of Institutions

335

Shares Held

53.7M

Call Options Held

540K

Put Options Held

306K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $2.6B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Haemonetics Corp Transaction History